graduation at Farmácia from Universidade de Ribeirão Preto (2020). , acting on the following subjects: célula tronco-tumoral, quimiorresistência, emt., hnscc, epigenetics, chemoresistance, cancer stem, oral cancer; cisplatin; cancer stem cells; emt, resistência intrínseca, resistência adquirida, emt and câncer oral, cisplatina.reprogramação epigenética.. (Source: Lattes Curriculum)
| News published in Agência FAPESP Newsletter about the researcher |
| More itemsLess items |
| TITULO |
| Articles published in other media outlets ( ): |
| More itemsLess items |
| VEICULO: TITULO (DATA) |
| VEICULO: TITULO (DATA) |
Head and Neck cancer is the sixth most prevalent cancer worldwide. It involves a heterogeneous group of tumors that originates from the lip, oral cavity, oropharyngeal, hypopharyngeal, laryngeal, sinonasal tract and nasopharyngeal. These tumors are commonly classified as squamous cell carcinomas. They constitute 90% of the Head and Neck cancers and they present high rates of recurrence, m…
Acquired resistance to therapeutic agents is a serious issue in cancer treatment. Over 7.5 million people die every year because of failures in the therapy due chemoresistance. Cisplatin is the one of the most used therapeutic drugs in cancer treatment, including in Head and neck squamous cell carcinoma (HNSCC), and several patients develop resistance to cisplatin. Patients respond well i…
| 2 / 2 | Completed scholarships in Brazil |
| Associated processes | |
CV Lattes
ORCID